Kris Sterkens says the healthcare system needs to transition from treating disease to preventing illness and could well adopt a Netflix model whereby payers take out a subscription and spread their payments for costly therapies over a number of years.

Proteus Medical Health has invented the world’s first digital pill, with a view to surmounting the problem of patients failing to take medicines as prescribed. Andrew Thompson explains how the collection, analysis and application of data will be central to the new health economy.

Mark O'Herlihy explains how and why machine learning will be fundamental to the healthcare of tomorrow, admitting that there is still a great deal of work to be done to demystify the role of new technologies by identifying proven results and best practice.

“We are years ahead of any competitor that may appear in the future,” says Claudia Jimenez, General Manager of biotech company ALGENEX, which uses moths to develop vaccines.

Stephan Sturm, Global CEO of Fresenius Group, says that we are fast approaching a new world of care, with a much stronger focus on prevention and more personalised treatment pathways.

Micro-immunotherapy can be used as supportive therapy for diseases which are the consequence of an imbalance in the immune system and has far fewer side effects than other treatments, explains Ian Wilders, Labo’Life’s Group CEO.

Laurent Monnerat of Zoetis explains how digital disruption is having a considerable impact on how animal health is being practiced.

Michael Schmelmer, CFO at Boehringer Ingelheim outlines his firm’s efforts to excel in pharma’s digital future and the abundant opportunities that lie therein.